Arterial Thromboembolism

Abstract Number: PB0030

A Population Cohort Study to Evaluate the Risk of Ischemic Stroke Among Individuals with a New Diagnosis of Cancer Compared to Matched Cancer-Free Controls: Impact of Prior Stroke History

D. Siegal¹, J. Cerasuolo², M. Carrier³, P. Gross⁴, M. Kapral⁵, R. Lun⁶, M. Shamy⁶, R. Sutradhar⁵

Abstract Number: PB0018

Activated protein C reduces maladaptive unfolded protein response (UPR) to ameliorate diabetes-accelerated atherosclerosis

S. Fatima¹, I. Gadi², S. Ambreen¹, K. Singh³, A. Gupta³, A. Elwakiel², S. Krishnan¹, A. Methew⁴, H. Khawaja⁵, S. Kohli², B. Isermann², K. Shahzad²

Abstract Number: PO0006

Activity of some coagulative factors and fibrinolysis in patients with arterial hipertension with concomitant diabetes type 2 depending on the carriIage of MTHFR C677T polymorphic genotypes

E. Shorikov¹, D. Shorikova¹, P. Shorikov², A. Esmaeil²

Abstract Number: VPB0523

Acute arterial limb ischemia after intake of amphetamine derivatives, report of two cases

A. Restrepo¹, A. Arango², R. Herrera³, J. Arrieta³

Abstract Number: OC 18.5

APAC Treatment Limits Collar-induced Carotid Atherosclerotic Plaque Development in ApoE-/- Mice

I. Bot¹, A. Jouppila², L. Delfos¹, E. Hemme¹, P. Kovanen³, R. Lassila⁴

Abstract Number: PB0494

Apixaban plasma levels at time of elective surgery: preliminary data from the DALI study

E. Camilleri¹, P. Shahbabai², M. Rad³, E. van Dorp⁴, L. Visser², S. Cannegieter¹, N. van Rein¹

Abstract Number: VPB0515

Assessing the cardiovascular risk in patients with Systemic Lupus Erythematosus: QRISK and GAPSS scores head to head

A. Barinotti, M. Radin, I. Cecchi, S. Foddai, E. Rubini, D. Roccatello, E. Menegatti, S. Sciascia

Abstract Number: OC 71.5

Assessment of DOACs in GEriatrics (ADAGE) study: rivaroxaban and apixaban plasma concentrations and thrombin generation profiles in very elderly patients with non valvular atrial fibrillation

G. FOULON-PINTO¹, C. LAFUENTE-LAFUENTE², G. JOURDI³, J. LE GUEN⁴, F. TALL⁵, E. PUYMIRAT⁴, M. DELRUE⁶, L. RIVIERE⁷, F. KETZ⁸, I. Gouin⁹, F. Mullier¹⁰, P. GAUSSEM¹¹, E. PAUTAS¹², T. LECOMPTE¹³, E. CURIS¹⁴, V. SIGURET³

Abstract Number: VPB0520

Assessment of thrombogenesis activity after endovascular treatment of coronary arteries

I. Vasilenko¹, D. Kassina², G. Shekhyan², M. Popov², Z. Kardashova²

Abstract Number: PB0031

Association between thromboembolus composition and first pass recanalisation after thrombectomy in ischemic stroke

S. Staessens¹, S. Vandelanotte², O. François³, E. Boulleaux⁴, M. Bretzner⁴, B. Casolla⁵, D. Corseaux⁴, L. Puy⁶, L. Desender¹, T. Dewaele³, C. Tersteeg⁷, K. Vanhoorelbeke⁷, P. Vanacker⁸, S. Susen⁹, C. Cordonnier⁶, T. Andersson¹⁰, S. De Meyer⁷

Abstract Number: PB0512

Associations of Platelete P2y12 Receptor Polymorphism with Macroangiopathies in Patients with High Cardiovascular Risk

D. Shorikova, E. Shorikov, P. Shorikov, A. Esmaeil, O. Khukhlina

Abstract Number: PB0498

Atrial Fibrillation: Trends in Prevalence and Antithrombotic Prescriptions in the Community

L. Joosten¹, A. de Boer², E. van Eerde², S. van Doorn¹, A. Hoes², M. Bots², F. Rutten², G. Geersing²

Abstract Number: PB0019

Bambi-deficiency enhances adipose tissue browning, ameliorates dyslipidemia and confers protection against atherosclerosis

C. Lee¹, O. Merhi El Hassan El Abdallah¹, J. Monkman¹, K. Woollard¹, J. Crawley¹, I. Salles-Crawley²

Abstract Number: OC 71.3

Bleeding Outcomes for Patients on Anticoagulant and Antiplatelet Therapy

J. Schaefer¹, J. Errickson¹, X. Kong¹, M. Ali², S. Edupuganti¹, B. Haymart¹, S. Kaatz³, D. DeCamillo¹, E. Kline-Rogers⁴, V. Shah³, S. Sood¹, J. Froehlich⁴, G. Barnes¹

Abstract Number: PB0499

Bleeding risk assessment in end-stage kidney disease: validation of existing risk scores and evaluation of a machine learning-based approach

S. Nopp¹, C. Spielvogel¹, S. Schmaldienst², R. Klauser-Braun³, M. Lorenz⁴, B. Bauer⁵, I. Pabinger⁵, M. Säemann⁶, O. Königsbrügge⁷, C. Ay⁵

Abstract Number: OC 45.1

Circulatory microRNA-411-5p as a novel prognostic biomarker for major adverse cardiac events in patients with atrial fibrillation

S. Nopp¹, M. van der Bent², O. Königsbrügge³, D. Kraemmer¹, J. Wojta¹, I. Pabinger⁴, C. Ay⁴, A. Nossent²

Abstract Number: VPB0021

Correlations between oxidative stress, endothelial injury and coagulation activation in hypertensive patients with chronic kidney disease

O. Korzh, S. Krasnokutskiy, Y. Fylenko

Abstract Number: PB0009

Could Pharmacoinvasive Strategy Using Streptokinase Be an Alternative to Primary Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction in Resource Poor Settings?

A. Alex¹, M. Gowri², O. George³

Abstract Number: PB0026

Decreased Levels of Factor VIII During Acute Ischemic Stroke Predict Excellent Outcome Thirty Days After

M. El Horri¹, F. Bemmoussat¹, R. Messaoudi², M. Moueden², F. El Horri³, D. Benlaldj⁴, I. Khachaa¹, G. Khitri⁵, A. Chikh Khelifa⁶, M. Smahi¹, K. Benbouhadi¹, K. Kebir¹, S. Zatir¹, L. Benmahdi¹, H. BROUK⁷

Abstract Number: PB0508

Differential quantitative proteomics reveals potential molecular mechanisms responsible for platelet hyperactivity and increased thrombotic risk in diabetes mellitus patients.

R. Haghiri Limoudehi¹, N. Wolska², M. Moritz³, H. Voss³, H. Schlüter⁴, G. Pula⁵